Journal of Clinical Densitometry
Volume 10, Issue 1 , Pages 1-9, January 2007

Risk Factors for Prevalent Vertebral Fractures in Black and White Female Densitometry Patients

  • Tamara J. Vokes

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL
    • Corresponding Author InformationAddress correspondence to: Tamara J. Vokes, MD, Section of Endocrinology, University of Chicago, 5841 S. Maryland, MC1027, Chicago, IL 60637.
  • ,
  • Daniel L. Gillen

      Affiliations

    • Department of Statistics, University of California, Irvine, CA
  • ,
  • Ann T. Pham

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL
  • ,
  • Jeanne M. Lovett

      Affiliations

    • Department of Medicine, University of Chicago, Chicago, IL

Received 13 October 2006; received in revised form 7 November 2006; accepted 8 November 2006. published online 28 December 2006.

Abstract 

This cross-sectional study compared risk factors for prevalent vertebral fractures (diagnosed using densitometric spine image Vertebral Fracture Assessment [VFA]) in 176 black and 345 white women recruited during their clinical bone mineral density (BMD) testing at the University of Chicago Hospitals. We used logistic regression to assess the association of prevalent vertebral fractures and risk factors (age, height loss, history of nonvertebral fractures, BMD, and use of corticosteroids). The prevalence of vertebral fractures was 21% for both races. All risk factors of interest were significantly associated with vertebral fractures in white women. Among black women, only age and corticosteroid use were found to be significant predictors of presence of vertebral fracture(s). In women without history of corticosteroid use, the probability of having vertebral fracture(s) given age was lower (p=0.02) in black subjects. In 77 patients with a history of corticosteroid use, the probability of having vertebral fracture(s) was higher in black than in white women after adjustment for age (p=0.045), BMD (p=0.045), or cumulative corticosteroid dose (p=0.08). Fewer black women were prescribed pharmacologic therapy for osteoporosis, regardless of their BMD level and corticosteroid use. We conclude that use of corticosteroids may be associated with relatively greater vertebral fracture risk in blacks than in whites.

Key Words: Bone densitometry, corticosteroid osteoporosis, fracture risk, racial differences, Vertebral Fracture Assessment (VFA), vertebral fractures

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented in part at the 2006 Annual Meeting of the International Society of Clinical Densitometry.

PII: S1094-6950(06)00308-8

doi:10.1016/j.jocd.2006.11.002

Journal of Clinical Densitometry
Volume 10, Issue 1 , Pages 1-9, January 2007